Indianapolis - Elano, the animal-health division of Eli Lilly and Co., has made an upspecified offer to acquire the animal-health portfolio owned by Janssen Pharmaceutica, a Johnson & Johnson company.
INDIANAPOLIS — Elanco, the animal-health division of Eli Lilly and Co., has made an unspecified offer to acquire the animal-health portfolio owned by Janssen Pharmaceutica, a Johnson & Johnson company.
The deal would give Elanco approximately 50 new animal-health products and move Janssen employees to Elanco. No manufacturing facilities would be affected by the acquisition, Elanco officials report.
The Future of Artificial Intelligence in Veterinary Diagnostics
May 2nd 2025Veterinary diagnostics are evolving fast - AI has the potential to make tests quicker, smarter, and more accurate. From blood analysis to imaging, innovations like Vetscan OptiCell™ and Vetscan Imagyst® are changing the game. Abhay Nayak, President of Global Diagnostics at Zoetis, gives his insights.
Read More